Source link : https://newshealth.biz/health-news/semaglutide-tied-to-50-lower-risk-for-epilepsy-in-diabetes/
The GLP-1 RA, semaglutide, significantly reduces epilepsy risk in diabetes, and this protective signal is driven by pathways unrelated to improvements in A1c or body weight. Medscape Medical News Source link : https://www.medscape.com/viewarticle/semaglutide-tied-50-lower-risk-epilepsy-diabetes-2025a1000ynf?src=rss Author : Publish date : 2025-12-10 13:18:00 Copyright for syndicated content belongs to the linked Source.
The post Semaglutide Tied to 50% Lower Risk for Epilepsy in Diabetes first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-10 13:18:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8